TrialOphthalmology2012

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.